Biosearch: bounce after the abyss
Sustained ripresina for Biosearch, after heavy losses’ s last seventh, that only in session on Friday had reversed the trend, scoring an excellent +4.22%. Last Thursday, the title had touched a record low of 25.1 euros, while today the title is better than Numtel, its benchmark, and share of 26.91 euros, a gain of 2.87%.
Related posts
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
Comments are closed.